Merus マネジメント
マネジメント 基準チェック /44
Merusの CEO はBill Lundbergで、 Dec2019年に任命され、 の在任期間は 4.92年です。 の年間総報酬は$ 4.67Mで、 13.9%給与と86.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.22%を直接所有しており、その価値は$ 6.92M 。経営陣と取締役会の平均在任期間はそれぞれ2.8年と6.3年です。
主要情報
Bill Lundberg
最高経営責任者
US$4.7m
報酬総額
| CEO給与比率 | 13.9% |
| CEO在任期間 | 4.9yrs |
| CEOの所有権 | 0.2% |
| 経営陣の平均在職期間 | 2.8yrs |
| 取締役会の平均在任期間 | 6.3yrs |
経営陣の近況
Recent updates
Merus: Petosemtamab Set Up For December 2024 Data Presentation
Nov 05We're Hopeful That Merus (NASDAQ:MRUS) Will Use Its Cash Wisely
Sep 20
Merus N.V.'s Innovative Cancer Therapies: Balancing Its IP Potential With Financial Risks
Aug 14Analysts Just Made A Major Revision To Their Merus N.V. (NASDAQ:MRUS) Revenue Forecasts
Jun 01Merus Stock: Priced High After An ASCO Surprise Surge (Maintain Buy)
May 24Earnings Beat: Merus N.V. (NASDAQ:MRUS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 12Merus (NASDAQ:MRUS) Is In A Good Position To Deliver On Growth Plans
May 10Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
Mar 01Merus N.V.'s (NASDAQ:MRUS) Shares Climb 30% But Its Business Is Yet to Catch Up
Feb 01Merus Stock: Rally Seems Overdone
Jan 23Are Investors Undervaluing Merus N.V. (NASDAQ:MRUS) By 45%?
Jan 14Risks To Shareholder Returns Are Elevated At These Prices For Merus N.V. (NASDAQ:MRUS)
Dec 18We Think Merus (NASDAQ:MRUS) Needs To Drive Business Growth Carefully
Sep 19Merus N.V.'s (NASDAQ:MRUS) Business Is Yet to Catch Up With Its Share Price
Jun 20Is Merus (NASDAQ:MRUS) In A Good Position To Invest In Growth?
May 24Merus N.V. (NASDAQ:MRUS) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 08Merus GAAP EPS of -$0.13 beats by $0.49, revenue of $12.68M beats by $2.23M
Aug 08Merus N.V. initiated with Buy at Stifel based on three bispecific antibodies
Aug 02Merus: Precision Oncology Pioneer Continues To Execute In The Clinic
Jun 30Need To Know: Analysts Are Much More Bullish On Merus N.V. (NASDAQ:MRUS)
May 14Merus (NASDAQ:MRUS) Is In A Strong Position To Grow Its Business
Apr 25New Forecasts: Here's What Analysts Think The Future Holds For Merus N.V. (NASDAQ:MRUS)
Mar 03We're Not Worried About Merus' (NASDAQ:MRUS) Cash Burn
Nov 25News Flash: Analysts Just Made A Sizeable Upgrade To Their Merus N.V. (NASDAQ:MRUS) Forecasts
Aug 08Calculating The Intrinsic Value Of Merus N.V. (NASDAQ:MRUS)
Jul 28We're Not Very Worried About Merus' (NASDAQ:MRUS) Cash Burn Rate
Jul 02CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$245m |
| Jun 30 2024 | n/a | n/a | -US$168m |
| Mar 31 2024 | n/a | n/a | -US$150m |
| Dec 31 2023 | US$5m | US$650k | -US$155m |
| Sep 30 2023 | n/a | n/a | -US$177m |
| Jun 30 2023 | n/a | n/a | -US$178m |
| Mar 31 2023 | n/a | n/a | -US$152m |
| Dec 31 2022 | US$6m | US$599k | -US$131m |
| Sep 30 2022 | n/a | n/a | -US$64m |
| Jun 30 2022 | n/a | n/a | -US$54m |
| Mar 31 2022 | n/a | n/a | -US$76m |
| Dec 31 2021 | US$8m | US$582k | -US$67m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$89m |
| Mar 31 2021 | n/a | n/a | -US$79m |
| Dec 31 2020 | US$5m | US$565k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$65m |
| Dec 31 2019 | US$162k | n/a | -US$55m |
報酬と市場: Billの 総報酬 ($USD 4.67M ) は、 US市場 ($USD 6.54M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Billの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Bill Lundberg (61 yo)
4.9yrs
在職期間
US$4,671,327
報酬
Dr. Sven Ante Lundberg, also known as Bill, M.D. is Venture Advisor of Forge Life Science Partners. He serves as Chief Executive Officer, President and Executive Director of Merus N.V. since December 31, 2...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Executive Director | 4.9yrs | US$4.67m | 0.22% $ 6.9m | |
| Chief Financial Officer | 1.4yrs | US$6.21m | 0% $ 0 | |
| EVP, Company Secretary | 6.8yrs | US$1.95m | データなし | |
| Co-Founder and Scientific Advisor | no data | データなし | データなし | |
| Chief Accounting Officer | no data | データなし | 0.010% $ 318.6k | |
| CTO & Executive VP | 11.8yrs | US$609.22k | データなし | |
| Chief Scientific Officer & Senior VP | 3.5yrs | データなし | データなし | |
| IR & Corporate Communications Officer | no data | データなし | データなし | |
| Chief People Officer | no data | データなし | データなし | |
| Executive VP & Chief Commercial Officer | 2.8yrs | データなし | データなし | |
| Senior Vice President of Regulatory Affairs | 2.8yrs | データなし | データなし | |
| Senior Vice President of Clinical Development | 2.8yrs | データなし | データなし |
2.8yrs
平均在職期間
59yo
平均年齢
経験豊富な経営陣: MRUSの経営陣は 経験豊富 であると考えられます ( 2.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Executive Director | 5.4yrs | US$4.67m | 0.22% $ 6.9m | |
| Board Observer | 14.8yrs | データなし | データなし | |
| Independent Non-Executive Director | 3.5yrs | US$305.06k | 0% $ 0 | |
| Independent Chairman | 9.3yrs | US$417.56k | 0% $ 0 | |
| Independent Non-Executive Director | 4.4yrs | US$309.56k | 0% $ 0 | |
| Independent Non Executive Director | 9.4yrs | US$311.06k | 0.11% $ 3.3m | |
| Member of Scientific Advisory Board | 6.3yrs | データなし | データなし | |
| Independent Non-Executive Director | 5.4yrs | US$303.56k | 0% $ 0 | |
| Member of Scientific Advisory Board | 6.3yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 6.3yrs | データなし | データなし | |
| Independent Non-Executive Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | 6.3yrs | US$303.56k | 0% $ 0 |
6.3yrs
平均在職期間
59.5yo
平均年齢
経験豊富なボード: MRUSの 取締役会 は 経験豊富 であると考えられます ( 6.3年の平均在任期間)。